Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05099276 · ClinicalTrials.gov registry record · Phase 4
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
A Phase 4 study of Pain, Postoperative and Knee Osteoarthritis, sponsored by Campbell Clinic.
- Active
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT05099276: Active Phase 4 study of Pain, Postoperative and Knee Osteoarthritis, sponsored by Campbell Clinic.
NCT05099276 is a Phase 4 study of Pain, Postoperative and Knee Osteoarthritis that is active but no longer recruiting, run by Campbell Clinic. The registered enrollment target is 46 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05099276, a Phase 4 study of Pain, Postoperative and Knee Osteoarthritis, is active but no longer recruiting, sponsored by Campbell Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tranexamic Acid Pill
Study Locations (1)
Tennessee
- Campbell Clinic - Germantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2024-06-01 |
| Phase | Phase 4 |
What the registry record for NCT05099276 still lists
NCT05099276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05099276 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05099276 about?
NCT05099276 is a clinical study titled "Extended Postoperative Oral Tranexamic Acid in Knee Replacement". A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.
What is the current status of trial NCT05099276?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2021-12-07. Estimated completion is 2024-06-01.
What conditions does trial NCT05099276 study?
This clinical trial studies the following conditions: Pain, Postoperative, Knee Osteoarthritis, Blood Loss.
What interventions are being tested in trial NCT05099276?
The interventions under investigation include: Placebo (DRUG), Tranexamic Acid Pill (DRUG).
Who is sponsoring clinical trial NCT05099276?
This trial is sponsored by Campbell Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05099276 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05099276's enrollment target sits among peer trials
46 95th of 113 higher than 19 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI